Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 9/20 | 0.59 |
| ▸ | S1PR3 | Q99500 | 7/20 | 0.59 |
| ▸ | S1PR4 | O95977 | 6/20 | 0.59 |
| ▸ | S1PR5 | Q9H228 | 5/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13614223 | 0.84 | FFAR1 (0.52) | LMNAL3MBTL1KDM4E | |
| SCHEMBL4820710 | 0.83 | S1PR1 (0.61) | S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL4820723 | 0.83 | S1PR1 (0.61) | S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL3289841 | 0.82 | S1PR1 (0.73) | S1PR1S1PR3S1PR4S1PR5LMNA | |
| SCHEMBL3289846 | 0.82 | S1PR1 (0.73) | S1PR1S1PR3S1PR4S1PR5LMNA | |
| SCHEMBL7615830 | 0.80 | S1PR1 (0.57) | S1PR1S1PR3S1PR4S1PR5LMNA | |
| SCHEMBL7614731 | 0.80 | S1PR1 (0.57) | S1PR1S1PR3S1PR4S1PR5LMNA | |
| SCHEMBL7615879 | 0.80 | S1PR1 (0.57) | S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL10459179 | 0.78 | S1PR1 (0.46) | S1PR1S1PR3S1PR4S1PR5LMNA | |
| SCHEMBL7614973 | 0.78 | S1PR1 (0.55) | S1PR1S1PR3S1PR4S1PR5LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612238-B2 | Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases | NOVARTIS AG (CH) | 2009-11-03 | — | — | US | disclosed |